
According to the 2022 annual report by BAT, Vuse's market share reached 35.9% in 2022, representing a YoY increase of 2.5%.
Vuse has achieved a leading market share in the United States, with a market share of 40.9% and a year-on-year growth of 8.4%. It is in the lead position in 35 states. The number of consumers has grown by 1.6 million, reaching 10 million.
In Canada, BAT has launched its first connected vapor device, Vuse ePod2+, expanding its leading market share position. Vuse ePod2+ grew by 8.9% in 2022, reaching 89.5% and making up 72% of all tracked channel sales.
In Europe, Vuse's revenue has grown by 37.9% and its sales have increased by 13.9%. Its disposable market share continues to rise, reaching 64.3% and growing by 8.3%. However, BAT has stated that the growth of disposable e-cigarettes will affect its overall market share for e-cigarette products, causing it to decrease by 16.7% by 2022.
In France, the market share is at 38.8%, a decrease of 6.3%, but still maintaining its position as the market leader.
In Germany, it holds a market share of 21.4%, which is a decrease of 37.9%, but it still retains its leading position in the market.
In the UK, the value share decreased by 14.7%, now accounting for 14.8%.
Furthermore, in the second half of 2022, BAT launched a new disposable product called Vuse Go in multiple markets including the UK, France, and Germany. It ranks second in the disposable e-cigarette sub-market.
Reference:
New category growth to boost profitability through 2024.
Related Reading
The annual report of BAT (British American Tobacco) states that their electronic cigarette business in the United States is the fastest growing, with emerging markets experiencing growth of more than 50%.
British American Tobacco (BAT) is expected to generate revenue of £27.7 billion in 2022. Their electronic cigarette business is expected to turn a profit one year earlier than previously anticipated.
British American Tobacco announces its complete withdrawal from the markets of Russia and Belarus by the year 2023.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









